Kristin Joly

Kristin Joly has extensive work experience in the biopharmaceutical industry. Kristin is currently working as the Director of In Vivo Operations at Inotiv since October 2021. Before their current role, they worked at Plato BioPharma, Inc. for 11 years. Kristin started as a Sr. Research Associate II in June 2010 and eventually became the Associate Director of In Vivo Operations in July 2016, a position they held until October 2021. Prior to their time at Plato BioPharma, Inc., Kristin worked at Gilead Sciences as a Sr. Research Associate I from May 2005 to December 2009.

Kristin Joly pursued their education at the University of Scranton from 1997 to 2001, where they obtained a Bachelor of Science degree in Biology. Following this, they enrolled at the University of New Haven for the period of 2003 to 2005, where they completed a Master of Science degree in Forensic Science.